Skip to content

Ayurvedic management of diabetic complication

Determination of Efficacies of Yashtavhadi Basti and Mustaaâ??Aamalaki Siddha Takra Dhaaraa followed by Guduchi and Aamalaki Churna in the management of Madhumeha Janya Daahaa W.S.R. to Diabetic Neuropathy (A Comparative Clinical Study)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011317
Enrollment
30
Registered
2018-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Madhumeha janya Daahaa(Diabetic Neuropathy)

Interventions

Intervention1: Mustaa â?? Aamalaki Siddha Takra Dhaaraa for 8 days followed by the oral administration of rasayana dravya Churna: Mustaa(cyperus rotundus) â?? Aamalaki(emblica officinelis)Siddha Takr

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with positive clinical history of type 2 diabetes mellitus with the symptoms of neuropathy (peripheral). 2.Patients fit for Basti Karma, Takra Dhaaraa. 3.Metabolically stable diabetic patients with symptomatic diabetic sensory motor polyneuropathy.

Exclusion criteria

Exclusion criteria: 1.Associated serious clinical conditions. 2.End stage renal disease. 3.Uncontrolled diabetes mellitus 4.Other metabolic and endocrinal disorders. 5.Suffering from infectious diseases. 6.Non-healing ulcer/ulcers.

Design outcomes

Primary

MeasureTime frame
Response in burning sensation in limbsTimepoint: 38 days

Secondary

MeasureTime frame
overall improvement of quality of life in diabetic neuropathy(MOS SF-36)Timepoint: 90 days

Countries

India

Contacts

Public ContactDr Santosh Kumar Bhatted

All india institute of ayurvda

santoshbhatted@rediffmail.com9414048459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026